Her2 Antibodies Market - An Overview of Growth Factors
Human epidermal growth factor receptor 2 (Her2) is an oncogene whose amplification or over-expression is observed to be associated with an aggressive type of breast cancer. Patients with amplified Her2 receptors are identified by tests such as Immunohistochemistry (IHC) and Fluorescent In-Situ Hybridization (FISH). According to the American Cancer Society, approximately 15% - 30% of breast cancers over-express the Her2 gene, whereas the Breast Cancer Society of Canada estimates the prevalence to be approximately 25%.
View full press release